Exact Mass: 1418.7041248
Exact Mass Matches: 1418.7041248
Found 7 metabolites which its exact mass value is equals to given mass value 1418.7041248,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-
4-[(2-Amino-1-hydroxyethylidene)amino]-5-(2-{2-[2-({[(6-amino-1-{2-[(1-{[2-carboxy-1-({2-carboxy-1-[(1-{[({1-[(1-carboxy-2-methylpropyl)-C-hydroxycarbonimidoyl]-3-methylbutyl}-C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}ethyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-C-hydroxycarbonimidoyl]pyrrolidin-1-yl}-1-oxohexan-2-yl)-C-hydroxycarbonimidoyl]methyl}-C-hydroxycarbonimidoyl)pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl}pyrrolidin-1-yl)-5-oxopentanoate
L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-
L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-
D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents BPC 157 is a stable gastric pentadecapeptide and a partial sequence of the human gastric juice protein BPC. BPC 157 is an anti-ulcer peptidergic agent with no reported toxicity. BPC 157 links inflammatory bowel disease and multiple sclerosis[1][2].
L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-
4-[(2-Amino-1-hydroxyethylidene)amino]-5-(2-{2-[2-({[(6-amino-1-{2-[(1-{[2-carboxy-1-({2-carboxy-1-[(1-{[({1-[(1-carboxy-2-methylpropyl)-C-hydroxycarbonimidoyl]-3-methylbutyl}-C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}ethyl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-C-hydroxycarbonimidoyl]pyrrolidin-1-yl}-1-oxohexan-2-yl)-C-hydroxycarbonimidoyl]methyl}-C-hydroxycarbonimidoyl)pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl}pyrrolidin-1-yl)-5-oxopentanoate
(4r)-4-{[(1r,2r)-1-{[(3s,6r,9s,12s,15s,18r,21s)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carboxymethyl)-2,5,8,11,14,17,20-heptahydroxy-3-(c-hydroxycarbonimidoylmethyl)-9-(3h-imidazol-4-ylmethyl)-1,4,7,10,13,16,19-heptaazacyclopentacosa-1,4,7,10,13,16,19-heptaen-21-yl]-c-hydroxycarbonimidoyl}-2-methylbutyl]-c-hydroxycarbonimidoyl}-4-{[(2s)-1-hydroxy-2-{[hydroxy({2-[(2r)-2-methylbutanoyl]-1,3-thiazol-4-yl})methylidene]amino}-4-methylpentylidene]amino}butanoic acid
(4r)-4-{[(1r,2r)-1-{[(3s,6r,9s,12s,15s,18r,21s)-18-(3-aminopropyl)-12-benzyl-15-[(2s)-butan-2-yl]-6-(carboxymethyl)-2,5,8,11,14,17,20-heptahydroxy-3-(c-hydroxycarbonimidoylmethyl)-9-(3h-imidazol-4-ylmethyl)-1,4,7,10,13,16,19-heptaazacyclopentacosa-1,4,7,10,13,16,19-heptaen-21-yl]-c-hydroxycarbonimidoyl}-2-methylbutyl]-c-hydroxycarbonimidoyl}-4-{[(2s)-1-hydroxy-2-{[hydroxy({2-[(2r)-2-methylbutanoyl]-1,3-thiazol-4-yl})methylidene]amino}-4-methylpentylidene]amino}butanoic acid
4-[(1-{[18-(3-aminopropyl)-12-benzyl-6-(carboxymethyl)-2,5,8,11,14,17,20-heptahydroxy-3-(c-hydroxycarbonimidoylmethyl)-9-(3h-imidazol-4-ylmethyl)-15-(sec-butyl)-1,4,7,10,13,16,19-heptaazacyclopentacosa-1,4,7,10,13,16,19-heptaen-21-yl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]-4-{[1-hydroxy-2-({hydroxy[2-(2-methylbutanoyl)-1,3-thiazol-4-yl]methylidene}amino)-4-methylpentylidene]amino}butanoic acid
4-[(1-{[18-(3-aminopropyl)-12-benzyl-6-(carboxymethyl)-2,5,8,11,14,17,20-heptahydroxy-3-(c-hydroxycarbonimidoylmethyl)-9-(3h-imidazol-4-ylmethyl)-15-(sec-butyl)-1,4,7,10,13,16,19-heptaazacyclopentacosa-1,4,7,10,13,16,19-heptaen-21-yl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]-4-{[1-hydroxy-2-({hydroxy[2-(2-methylbutanoyl)-1,3-thiazol-4-yl]methylidene}amino)-4-methylpentylidene]amino}butanoic acid